Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.

Kreuter, A; Burmann, S-N; Burkert, B; Oellig, F; Michalowitz, A-L

Kreuter, A; Burmann, S-N; Burkert, B; Oellig, F; Michalowitz, A-L.

Afiliación

Kreuter A; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
Burmann SN; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
Burkert B; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
Oellig F; Institute of Pathology, Mülheim an der Ruhr, Germany.
Michalowitz AL; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.

J Eur Acad Dermatol Venereol ; 35(11): e733-e735, 2021 Nov.

Article en En | MEDLINE | ID: mdl-34243220

Asunto(s)

COVID-19; Lupus Eritematoso Cutáneo; Lupus Eritematoso Sistémico; Vacunas contra la COVID-19; Humanos; SARS-CoV-2; Vacunación

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / COVID-19 / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google